secwatch.observer — SEC 8-K summary
======================================

Issuer:     EKSO BIONICS HOLDINGS, INC. (CHRN)
CIK:        0001549084
Form:       8-K
Filed at:   2026-01-22T23:59:59+00:00
Accession:  0001437749-26-001774
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ekso Bionics raises ~$5.3M net via private placement of Series B convertible preferred and warrants
--------------------------------------------------------------------------------

- Issued 5,852 shares of Series B Convertible Preferred Stock (stated value $1,000/share) and warrants for 355,960 shares.
- Conversion price and warrant exercise price set at $8.22 per share of common stock; 6-month lock-up on transfers.
- Net proceeds of ~$5.3M after ~$0.4M placement agent fees; intended for working capital and general corporate purposes.
- Filed Certificate of Designation for Series B Preferred with Nevada Secretary of State on January 22, 2026.
- Lake Street Capital Markets acted as exclusive placement agent; received a 6% cash fee and a warrant for 14,238 shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1549084/000143774926001774/0001437749-26-001774-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1549084/000143774926001774/ekso20260122_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-001774

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer